Innoviva Stock Book Value Per Share

INVA Stock

USD 15.16 0.01 0.07%

Innoviva fundamentals help investors to digest information that contributes to Innoviva's financial success or failures. It also enables traders to predict the movement of Innoviva Stock. The fundamental analysis module provides a way to measure Innoviva's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Innoviva stock.

	Last Reported	Projected for Next Year
Book Value Per Share	18.71	19.64
Tangible Book Value Per Share	11.83	12.42

The current year's Book Value Per Share is expected to grow to 19.64. The current year's Tangible Book Value Per Share is expected to grow to 12.42.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Innoviva Company Book Value Per Share Analysis

Innoviva's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Book Value per Share

Common Equity

Average Shares

More About Book Value Per Share | All Equity Analysis

Current Innoviva Book Value Per Share

10.66 X

Most of Innoviva's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innoviva is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Innoviva Book Value Per Share Driver Correlations

Understanding the fundamental principles of building solid financial models for Innoviva is extremely important. It helps to project a fair market value of Innoviva Stock properly, considering its historical fundamentals such as Book Value Per Share. Since Innoviva's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Innoviva's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Innoviva's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Current Deferred Revenue	Net Debt	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Treasury Stock	Intangible Assets	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.84	0.71	0.18	-0.05	-0.12	0.29	0.09	0.68	0.86	0.61	-0.2	-0.11	-0.35	0.76	0.03	-0.31	-0.03	0.49	-0.46	0.34	-0.56	0.93	0.81	-0.83
Total Stockholder Equity	0.84		0.86	-0.37	0.12	-0.62	0.42	-0.44	0.51	0.81	0.58	-0.14	-0.43	0.09	0.92	-0.48	-0.22	-0.15	0.2	-0.03	-0.08	-0.37	0.83	0.74	-0.7
Retained Earnings	0.71	0.86		-0.36	0.0	-0.54	0.26	-0.42	0.49	0.64	0.22	-0.43	-0.76	0.2	0.67	-0.39	-0.56	0.06	0.22	-0.09	-0.06	-0.39	0.79	0.66	-0.77
Total Liab	0.18	-0.37	-0.36		-0.28	0.92	-0.24	0.97	0.18	-0.03	0.04	-0.05	0.57	-0.72	-0.38	0.89	-0.07	0.2	0.46	-0.69	0.8	-0.26	0.1	0.02	-0.15
Current Deferred Revenue	-0.05	0.12	0.0	-0.28		-0.4	0.5	-0.41	-0.47	0.18	0.24	0.23	-0.06	0.44	0.12	-0.46	0.25	-0.33	-0.53	0.58	-0.32	0.53	-0.06	-0.08	0.02
Net Debt	-0.12	-0.62	-0.54	0.92	-0.4		-0.4	0.95	0.04	-0.3	-0.27	0.01	0.57	-0.64	-0.62	0.92	-0.03	0.29	0.33	-0.61	0.7	-0.15	-0.2	-0.27	0.09
Accounts Payable	0.29	0.42	0.26	-0.24	0.5	-0.4		-0.45	-0.29	0.46	0.34	0.29	-0.13	0.46	0.25	-0.45	0.21	-0.48	-0.37	0.56	-0.03	0.27	0.15	-0.02	-0.37
Long Term Debt	0.09	-0.44	-0.42	0.97	-0.41	0.95	-0.45		0.22	-0.14	-0.03	-0.04	0.59	-0.78	-0.4	0.94	-0.05	0.25	0.51	-0.76	0.74	-0.28	0.03	0.0	-0.03
Net Receivables	0.68	0.51	0.49	0.18	-0.47	0.04	-0.29	0.22		0.48	0.21	-0.59	0.0	-0.67	0.59	0.19	-0.54	0.31	0.85	-0.76	0.19	-0.9	0.73	0.7	-0.55
Short Term Investments	0.86	0.81	0.64	-0.03	0.18	-0.3	0.46	-0.14	0.48		0.57	-0.05	-0.19	-0.12	0.78	-0.21	-0.14	-0.15	0.2	-0.13	-0.04	-0.32	0.79	0.59	-0.78
Total Current Assets	0.61	0.58	0.22	0.04	0.24	-0.27	0.34	-0.03	0.21	0.57		0.24	0.15	-0.12	0.64	-0.22	0.37	-0.32	0.13	-0.03	0.19	-0.16	0.53	0.64	-0.33
Short Term Debt	-0.2	-0.14	-0.43	-0.05	0.23	0.01	0.29	-0.04	-0.59	-0.05	0.24		0.35	0.22	-0.09	-0.08	0.77	-0.31	-0.61	0.44	-0.03	0.6	-0.39	-0.37	0.29
Common Stock	-0.11	-0.43	-0.76	0.57	-0.06	0.57	-0.13	0.59	0.0	-0.19	0.15	0.35		-0.65	-0.2	0.52	0.4	-0.06	0.15	-0.31	0.31	-0.02	-0.27	-0.16	0.39
Property Plant Equipment	-0.35	0.09	0.2	-0.72	0.44	-0.64	0.46	-0.78	-0.67	-0.12	-0.12	0.22	-0.65		-0.1	-0.7	0.24	-0.3	-0.75	0.9	-0.5	0.62	-0.32	-0.35	0.17
Net Tangible Assets	0.76	0.92	0.67	-0.38	0.12	-0.62	0.25	-0.4	0.59	0.78	0.64	-0.09	-0.2	-0.1		-0.49	-0.12	-0.15	0.27	-0.09	-0.23	-0.41	0.78	0.76	-0.53
Long Term Debt Total	0.03	-0.48	-0.39	0.89	-0.46	0.92	-0.45	0.94	0.19	-0.21	-0.22	-0.08	0.52	-0.7	-0.49		-0.14	0.32	0.43	-0.74	0.68	-0.24	-0.08	-0.1	0.01
Capital Surpluse	-0.31	-0.22	-0.56	-0.07	0.25	-0.03	0.21	-0.05	-0.54	-0.14	0.37	0.77	0.4	0.24	-0.12	-0.14		-0.57	-0.42	0.49	-0.1	0.54	-0.47	-0.41	0.44
Deferred Long Term Liab	-0.03	-0.15	0.06	0.2	-0.33	0.29	-0.48	0.25	0.31	-0.15	-0.32	-0.31	-0.06	-0.3	-0.15	0.32	-0.57		0.13	-0.45	0.18	-0.46	0.06	0.09	0.02
Long Term Investments	0.49	0.2	0.22	0.46	-0.53	0.33	-0.37	0.51	0.85	0.2	0.13	-0.61	0.15	-0.75	0.27	0.43	-0.42	0.13		-0.81	0.43	-0.82	0.58	0.52	-0.41
Treasury Stock	-0.46	-0.03	-0.09	-0.69	0.58	-0.61	0.56	-0.76	-0.76	-0.13	-0.03	0.44	-0.31	0.9	-0.09	-0.74	0.49	-0.45	-0.81		-0.6	0.72	-0.47	-0.47	0.32
Intangible Assets	0.34	-0.08	-0.06	0.8	-0.32	0.7	-0.03	0.74	0.19	-0.04	0.19	-0.03	0.31	-0.5	-0.23	0.68	-0.1	0.18	0.43	-0.6		-0.32	0.25	0.18	-0.29
Short Long Term Debt	-0.56	-0.37	-0.39	-0.26	0.53	-0.15	0.27	-0.28	-0.9	-0.32	-0.16	0.6	-0.02	0.62	-0.41	-0.24	0.54	-0.46	-0.82	0.72	-0.32		-0.63	-0.61	0.46
Net Invested Capital	0.93	0.83	0.79	0.1	-0.06	-0.2	0.15	0.03	0.73	0.79	0.53	-0.39	-0.27	-0.32	0.78	-0.08	-0.47	0.06	0.58	-0.47	0.25	-0.63		0.87	-0.81
Net Working Capital	0.81	0.74	0.66	0.02	-0.08	-0.27	-0.02	0.0	0.7	0.59	0.64	-0.37	-0.16	-0.35	0.76	-0.1	-0.41	0.09	0.52	-0.47	0.18	-0.61	0.87		-0.6
Capital Stock	-0.83	-0.7	-0.77	-0.15	0.02	0.09	-0.37	-0.03	-0.55	-0.78	-0.33	0.29	0.39	0.17	-0.53	0.01	0.44	0.02	-0.41	0.32	-0.29	0.46	-0.81	-0.6

Click cells to compare fundamentals

The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.

Competition

Predict Innoviva

Book Value Per Share Over Time

Innoviva Common Stock Shares Outstanding

Common Stock Shares Outstanding

34.27 Million

At present, Innoviva's Common Stock Shares Outstanding is projected to decrease significantly based on the last few years of reporting.

In accordance with the recently published financial statements, the book value per share of Innoviva is about 10.662 times. This is 727.18% lower than that of the Pharmaceuticals sector and 104.29% lower than that of the Health Care industry. The book value per share for all United States stocks is 99.45% higher than that of the company.

Innoviva Book Value Per Share Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innoviva's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Innoviva could also be used in its relative valuation, which is a method of valuing Innoviva by comparing valuation metrics of similar companies.

Innoviva is currently under evaluation in book value per share category among related companies.

Innoviva Fundamentals

	Return On Equity	0.29
	Return On Asset	0.0712
	Profit Margin	0.58 %
	Operating Margin	0.53 %
	Current Valuation	1.21 B
	Shares Outstanding	63.23 M
	Shares Owned By Insiders	1.50 %
	Shares Owned By Institutions	98.50 %
	Number Of Shares Shorted	11.33 M
	Price To Earning	5.67 X
	Price To Book	1.37 X
	Price To Sales	2.98 X
	Revenue	324.26 M
	Gross Profit	276.11 M
	EBITDA	149.59 M
	Net Income	179.72 M
	Cash And Equivalents	283.58 M
	Cash Per Share	4.07 X
	Total Debt	449.08 M
	Debt To Equity	0.96 %
	Current Ratio	3.18 X
	Book Value Per Share	10.66 X
	Cash Flow From Operations	141.06 M
	Short Ratio	13.53 X
	Earnings Per Share	2.20 X
	Price To Earnings To Growth	0.24 X
	Target Price	15.0
	Number Of Employees	112
	Beta	0.57
	Market Capitalization	959.16 M
	Total Asset	1.24 B
	Retained Earnings	(25.19 M)
	Working Capital	306.08 M
	Current Asset	214.32 M
	Current Liabilities	13.49 M
	Net Asset	1.24 B

About Innoviva Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Innoviva's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innoviva using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innoviva based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Innoviva in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Innoviva's short interest history, or implied volatility extrapolated from Innoviva options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:

How To Invest In Innoviva

Details

Is Innoviva Stock a good investment?

Details

What is Innoviva's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Innoviva Piotroski F Score and Innoviva Altman Z Score analysis.

For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Innoviva Stock analysis

When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Equity Valuation Check real value of public entities based on technical and fundamental data

Is Innoviva's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.65)

Earnings Share

2.2

Revenue Per Share

4.745

Quarterly Revenue Growth

0.305

Return On Assets

0.0712

The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Innoviva Stock Book Value Per Share

Innoviva Company Book Value Per Share Analysis

Book Value per Share

Common Equity

Average Shares

Current Innoviva Book Value Per Share

Innoviva Book Value Per Share Driver Correlations

Innoviva Common Stock Shares Outstanding

Common Stock Shares Outstanding

34.27 Million

Innoviva Book Value Per Share Peer Comparison

Innoviva Fundamentals

About Innoviva Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Innoviva Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY